X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,623,000 | +33.9% | 536,962 | 0.0% | 0.07% | +45.8% |
Q4 2020 | $3,453,000 | -8.8% | 536,962 | -4.0% | 0.05% | -30.4% |
Q3 2020 | $3,788,000 | -27.3% | 559,494 | 0.0% | 0.07% | -32.4% |
Q2 2020 | $5,214,000 | -13.4% | 559,494 | -7.1% | 0.10% | -46.3% |
Q1 2020 | $6,023,000 | +108.3% | 602,274 | +122.8% | 0.19% | +115.9% |
Q4 2019 | $2,892,000 | -52.4% | 270,292 | -43.5% | 0.09% | -75.7% |
Q3 2019 | $6,077,000 | -53.0% | 478,107 | -44.5% | 0.36% | -47.8% |
Q2 2019 | $12,921,000 | – | 861,393 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |